Royal Bank of Scotland chairman to move to GlaxoSmithKline

Sir Philip Hampton to exchange similar roles from bailed out bank to embattled pharmaceutical company at the end of 2015

Sir Philip Hampton, chairman of Royal Bank of Scotland, is to quit his role at the helm of the bailed-out bank to take the same position at the embattled pharmaceutical company GlaxoSmithKline.

In coordinated announcements from the companies expected before the weekend, Hampton is to be named as successor to Sir Christopher Gent at GSK. Gent has said he intends to retire from the pharmaceutical company at the end of 2015.

Continue reading…
Pharmaceuticals industry | The Guardian

Pharmaceutical Stocks


© 2018 Drugs News All rights reserved.       Privacy Policy       Contact Us